Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1384913

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1384913

North America Metabolism Assays Market Size, Share & Industry Trends Analysis Report By Product, By Application, By Technology (Colorimetry, Fluorimetry and Spectrometry), By End User, By Country and Growth Forecast, 2023 - 2030

PUBLISHED:
PAGES: 137 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Multi User License)
USD 1800
PDF (Corporate User License)
USD 2520

Add to Cart

The North America Metabolism Assays Market would witness market growth of 6.9% CAGR during the forecast period (2023-2030).

Metabolism assays are used in life sciences and drug discovery to measure and study various metabolic processes within cells and organisms. These assays are crucial in understanding cellular metabolism, drug screening, toxicity testing, and disease research. The market for metabolism assays includes a wide range of products and services used by researchers in academia, pharmaceutical companies, biotechnology firms, and clinical laboratories.

The pharmaceutical industry's continuous need for new drugs and therapies has driven the demand for metabolism assays. These assays are used in early drug discovery, toxicity testing, and drug screening. As personalized medicine gains traction, there is a growing need for metabolism assays to tailor treatments to patients' metabolic profiles. Ongoing advancements in assay technology, such as high-throughput screening methods and the development of more accurate and sensitive assays, have expanded the market. The growing number of chronic diseases like diabetes and obesity has led to a heightened interest in studying metabolic pathways, fostering growth in the market.

North America has one of the highest prevalences of metabolic disorders, like obesity, diabetes, and cardiovascular diseases. This has led to a strong demand for metabolic assays for diagnosis, monitoring, and management. The aging population in North America is at an increased risk of metabolic disorders. The market continues to grow as healthcare providers, researchers, and patients recognize the critical role of these assays in addressing the challenges posed by chronic diseases. The above factors will boost the market's growth in this region.

The US market dominated the North America Metabolism Assays Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $644.7 million by 2030. The Canada market is experiencing a CAGR of 9.4% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 8.4% during (2023 - 2030).

Based on Product, the market is segmented into Assay Kits & Reagents and Instruments & Analyzers. Based on Application, the market is segmented into Diagnostics (Diabetes, Obesity, Cardiovascular Diseases, Cancer and Others) and Research. Based on Technology, the market is segmented into Colorimetry, Fluorimetry and Spectrometry. Based on End User, the market is segmented into Hospitals, Diagnostics Laboratories and Pharmaceutical & Biotechnology Companies and CROs & Academic Research Institutes. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Merck KGaA, Thermo Fisher Scientific, Inc., Abcam Plc, Agilent Technologies, Inc, Promega Corporation, Kaneka Eurogentec S.A (Kaneka Corporation), RayBiotech Life, Inc, Sartorius AG, Elabscience Biotechnology Inc. and Bmg Labtech GmbH.

Scope of the Study

Market Segments covered in the Report:

By Product

  • Instruments & Analyzers
  • Assay Kits & Reagents

By Application

  • Diagnostics
    • Diabetes
    • Obesity
    • Cardiovascular Diseases
    • Cancer
    • Others
  • Research

By Technology

  • Colorimetry
  • Fluorimetry
  • Spectrometry

By End User

  • Hospitals
  • Diagnostics Laboratories
  • Pharmaceutical & Biotechnology Companies and CROs & Academic Research Institutes

By Country

  • US
  • Canada
  • Mexico
  • Rest of North America

Companies Profiled

  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
  • Abcam Plc
  • Agilent Technologies, Inc
  • Promega Corporation
  • Kaneka Eurogentec S.A (Kaneka Corporation)
  • RayBiotech Life, Inc
  • Sartorius AG
  • Elabscience Biotechnology Inc
  • Bmg Labtech GmbH

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 North America Metabolism Assays Market, by Product
    • 1.4.2 North America Metabolism Assays Market, by Application
    • 1.4.3 North America Metabolism Assays Market, by Technology
    • 1.4.4 North America Metabolism Assays Market, by End User
    • 1.4.5 North America Metabolism Assays Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
  • 3.3 Porter's Five Forces Analysis

Chapter 4. Strategies Deployed in Metabolism Assays Market

Chapter 5. North America Metabolism Assays Market by Product

  • 5.1 North America Assay Kits & Reagents Market by Region
  • 5.2 North America Instruments & Analyzers Market by Region

Chapter 6. North America Metabolism Assays Market by Application

  • 6.1 North America Diagnostics Market by Region
  • 6.2 North America Metabolism Assays Market by Diagnostics Type
    • 6.2.1 North America Diabetes Market by Country
    • 6.2.2 North America Obesity Market by Country
    • 6.2.3 North America Cardiovascular Diseases Market by Country
    • 6.2.4 North America Cancer Market by Country
    • 6.2.5 North America Others Market by Country
  • 6.3 North America Research Market by Region

Chapter 7. North America Metabolism Assays Market by Technology

  • 7.1 North America Colorimetry Market by Country
  • 7.2 North America Fluorimetry Market by Country
  • 7.3 North America Spectrometry Market by Country

Chapter 8. North America Metabolism Assays Market by End User

  • 8.1 North America Hospitals Market by Country
  • 8.2 North America Diagnostics Laboratories Market by Country
  • 8.3 North America Pharmaceutical & Biotechnology Companies and CROs & Academic Research Institutes Market by Country

Chapter 9. North America Metabolism Assays Market by Country

  • 9.1 US Metabolism Assays Market
    • 9.1.1 US Metabolism Assays Market by Product
    • 9.1.2 US Metabolism Assays Market by Application
      • 9.1.2.1 US Metabolism Assays Market by Diagnostics Type
    • 9.1.3 US Metabolism Assays Market by Technology
    • 9.1.4 US Metabolism Assays Market by End User
  • 9.2 Canada Metabolism Assays Market
    • 9.2.1 Canada Metabolism Assays Market by Product
    • 9.2.2 Canada Metabolism Assays Market by Application
      • 9.2.2.1 Canada Metabolism Assays Market by Diagnostics Type
    • 9.2.3 Canada Metabolism Assays Market by Technology
    • 9.2.4 Canada Metabolism Assays Market by End User
  • 9.3 Mexico Metabolism Assays Market
    • 9.3.1 Mexico Metabolism Assays Market by Product
    • 9.3.2 Mexico Metabolism Assays Market by Application
      • 9.3.2.1 Mexico Metabolism Assays Market by Diagnostics Type
    • 9.3.3 Mexico Metabolism Assays Market by Technology
    • 9.3.4 Mexico Metabolism Assays Market by End User
  • 9.4 Rest of North America Metabolism Assays Market
    • 9.4.1 Rest of North America Metabolism Assays Market by Product
    • 9.4.2 Rest of North America Metabolism Assays Market by Application
      • 9.4.2.1 Rest of North America Metabolism Assays Market by Diagnostics Type
    • 9.4.3 Rest of North America Metabolism Assays Market by Technology
    • 9.4.4 Rest of North America Metabolism Assays Market by End User

Chapter 10. Company Profiles

  • 10.1 Merck KGaA
    • 10.1.1 Company Overview
    • 10.1.2 Financial Analysis
    • 10.1.3 Segmental and Regional Analysis
    • 10.1.4 Research & Development Expense
    • 10.1.5 SWOT Analysis
  • 10.2 Thermo Fisher Scientific, Inc.
    • 10.2.1 Company Overview
    • 10.2.2 Financial Analysis
    • 10.2.3 Segmental and Regional Analysis
    • 10.2.4 Research & Development Expenses
    • 10.2.5 Recent strategies and developments:
      • 10.2.5.1 Partnerships, Collaborations, and Agreements:
      • 10.2.5.2 Product Launches and Product Expansions:
    • 10.2.6 SWOT Analysis
  • 10.3 Abcam Plc
    • 10.3.1 Company Overview
    • 10.3.2 Financial Analysis
    • 10.3.3 Regional Analysis
    • 10.3.4 Research & Development Expenses
    • 10.3.5 Recent strategies and developments:
      • 10.3.5.1 Partnerships, Collaborations, and Agreements:
      • 10.3.5.2 Acquisition and Mergers:
    • 10.3.6 SWOT Analysis
  • 10.4 Agilent Technologies, Inc.
    • 10.4.1 Company Overview
    • 10.4.2 Financial Analysis
    • 10.4.3 Segmental and Regional Analysis
    • 10.4.4 Research & Development Expense
    • 10.4.5 Recent strategies and developments:
      • 10.4.5.1 Partnerships, Collaborations, and Agreements:
    • 10.4.6 SWOT Analysis
  • 10.5 Promega Corporation
    • 10.5.1 Company Overview
    • 10.5.2 SWOT Analysis
  • 10.6 Kaneka Eurogentec S.A (Kaneka Corporation)
    • 10.6.1 Company Overview
    • 10.6.2 Financial Analysis
    • 10.6.3 Segmental and Regional Analysis
    • 10.6.4 Research & Development Expenses
    • 10.6.5 SWOT Analysis
  • 10.7 RayBiotech Life, Inc.
    • 10.7.1 Company Overview
    • 10.7.2 SWOT Analysis
  • 10.8 Sartorius AG
    • 10.8.1 Company Overview
    • 10.8.2 Financial Analysis
    • 10.8.3 Segmental and Regional Analysis
    • 10.8.4 Research & Development Expenses
    • 10.8.5 SWOT Analysis
  • 10.9 Elabscience Biotechnology Inc.
    • 10.9.1 Company Overview
    • 10.9.2 SWOT Analysis
  • 10.10. Bmg Labtech GmbH
    • 10.10.1 Company Overview
    • 10.10.2 SWOT Analysis

LIST OF TABLES

  • TABLE 1 North America Metabolism Assays Market, 2019 - 2022, USD Million
  • TABLE 2 North America Metabolism Assays Market, 2023 - 2030, USD Million
  • TABLE 3 North America Metabolism Assays Market by Product, 2019 - 2022, USD Million
  • TABLE 4 North America Metabolism Assays Market by Product, 2023 - 2030, USD Million
  • TABLE 5 North America Assay Kits & Reagents Market by Region, 2019 - 2022, USD Million
  • TABLE 6 North America Assay Kits & Reagents Market by Region, 2023 - 2030, USD Million
  • TABLE 7 North America Instruments & Analyzers Market by Region, 2019 - 2022, USD Million
  • TABLE 8 North America Instruments & Analyzers Market by Region, 2023 - 2030, USD Million
  • TABLE 9 North America Metabolism Assays Market by Application, 2019 - 2022, USD Million
  • TABLE 10 North America Metabolism Assays Market by Application, 2023 - 2030, USD Million
  • TABLE 11 North America Diagnostics Market by Region, 2019 - 2022, USD Million
  • TABLE 12 North America Diagnostics Market by Region, 2023 - 2030, USD Million
  • TABLE 13 North America Metabolism Assays Market by Diagnostics Type, 2019 - 2022, USD Million
  • TABLE 14 North America Metabolism Assays Market by Diagnostics Type, 2023 - 2030, USD Million
  • TABLE 15 North America Diabetes Market by Country, 2019 - 2022, USD Million
  • TABLE 16 North America Diabetes Market by Country, 2023 - 2030, USD Million
  • TABLE 17 North America Obesity Market by Country, 2019 - 2022, USD Million
  • TABLE 18 North America Obesity Market by Country, 2023 - 2030, USD Million
  • TABLE 19 North America Cardiovascular Diseases Market by Country, 2019 - 2022, USD Million
  • TABLE 20 North America Cardiovascular Diseases Market by Country, 2023 - 2030, USD Million
  • TABLE 21 North America Cancer Market by Country, 2019 - 2022, USD Million
  • TABLE 22 North America Cancer Market by Country, 2023 - 2030, USD Million
  • TABLE 23 North America Others Market by Country, 2019 - 2022, USD Million
  • TABLE 24 North America Others Market by Country, 2023 - 2030, USD Million
  • TABLE 25 North America Research Market by Region, 2019 - 2022, USD Million
  • TABLE 26 North America Research Market by Region, 2023 - 2030, USD Million
  • TABLE 27 North America Metabolism Assays Market by Technology, 2019 - 2022, USD Million
  • TABLE 28 North America Metabolism Assays Market by Technology, 2023 - 2030, USD Million
  • TABLE 29 North America Colorimetry Market by Country, 2019 - 2022, USD Million
  • TABLE 30 North America Colorimetry Market by Country, 2023 - 2030, USD Million
  • TABLE 31 North America Fluorimetry Market by Country, 2019 - 2022, USD Million
  • TABLE 32 North America Fluorimetry Market by Country, 2023 - 2030, USD Million
  • TABLE 33 North America Spectrometry Market by Country, 2019 - 2022, USD Million
  • TABLE 34 North America Spectrometry Market by Country, 2023 - 2030, USD Million
  • TABLE 35 North America Metabolism Assays Market by End User, 2019 - 2022, USD Million
  • TABLE 36 North America Metabolism Assays Market by End User, 2023 - 2030, USD Million
  • TABLE 37 North America Hospitals Market by Country, 2019 - 2022, USD Million
  • TABLE 38 North America Hospitals Market by Country, 2023 - 2030, USD Million
  • TABLE 39 North America Diagnostics Laboratories Market by Country, 2019 - 2022, USD Million
  • TABLE 40 North America Diagnostics Laboratories Market by Country, 2023 - 2030, USD Million
  • TABLE 41 North America Pharmaceutical & Biotechnology Companies and CROs & Academic Research Institutes Market by Country, 2019 - 2022, USD Million
  • TABLE 42 North America Pharmaceutical & Biotechnology Companies and CROs & Academic Research Institutes Market by Country, 2023 - 2030, USD Million
  • TABLE 43 North America Metabolism Assays Market by Country, 2019 - 2022, USD Million
  • TABLE 44 North America Metabolism Assays Market by Country, 2023 - 2030, USD Million
  • TABLE 45 US Metabolism Assays Market, 2019 - 2022, USD Million
  • TABLE 46 US Metabolism Assays Market, 2023 - 2030, USD Million
  • TABLE 47 US Metabolism Assays Market by Product, 2019 - 2022, USD Million
  • TABLE 48 US Metabolism Assays Market by Product, 2023 - 2030, USD Million
  • TABLE 49 US Metabolism Assays Market by Application, 2019 - 2022, USD Million
  • TABLE 50 US Metabolism Assays Market by Application, 2023 - 2030, USD Million
  • TABLE 51 US Metabolism Assays Market by Diagnostics Type, 2019 - 2022, USD Million
  • TABLE 52 US Metabolism Assays Market by Diagnostics Type, 2023 - 2030, USD Million
  • TABLE 53 US Metabolism Assays Market by Technology, 2019 - 2022, USD Million
  • TABLE 54 US Metabolism Assays Market by Technology, 2023 - 2030, USD Million
  • TABLE 55 US Metabolism Assays Market by End User, 2019 - 2022, USD Million
  • TABLE 56 US Metabolism Assays Market by End User, 2023 - 2030, USD Million
  • TABLE 57 Canada Metabolism Assays Market, 2019 - 2022, USD Million
  • TABLE 58 Canada Metabolism Assays Market, 2023 - 2030, USD Million
  • TABLE 59 Canada Metabolism Assays Market by Product, 2019 - 2022, USD Million
  • TABLE 60 Canada Metabolism Assays Market by Product, 2023 - 2030, USD Million
  • TABLE 61 Canada Metabolism Assays Market by Application, 2019 - 2022, USD Million
  • TABLE 62 Canada Metabolism Assays Market by Application, 2023 - 2030, USD Million
  • TABLE 63 Canada Metabolism Assays Market by Diagnostics Type, 2019 - 2022, USD Million
  • TABLE 64 Canada Metabolism Assays Market by Diagnostics Type, 2023 - 2030, USD Million
  • TABLE 65 Canada Metabolism Assays Market by Technology, 2019 - 2022, USD Million
  • TABLE 66 Canada Metabolism Assays Market by Technology, 2023 - 2030, USD Million
  • TABLE 67 Canada Metabolism Assays Market by End User, 2019 - 2022, USD Million
  • TABLE 68 Canada Metabolism Assays Market by End User, 2023 - 2030, USD Million
  • TABLE 69 Mexico Metabolism Assays Market, 2019 - 2022, USD Million
  • TABLE 70 Mexico Metabolism Assays Market, 2023 - 2030, USD Million
  • TABLE 71 Mexico Metabolism Assays Market by Product, 2019 - 2022, USD Million
  • TABLE 72 Mexico Metabolism Assays Market by Product, 2023 - 2030, USD Million
  • TABLE 73 Mexico Metabolism Assays Market by Application, 2019 - 2022, USD Million
  • TABLE 74 Mexico Metabolism Assays Market by Application, 2023 - 2030, USD Million
  • TABLE 75 Mexico Metabolism Assays Market by Diagnostics Type, 2019 - 2022, USD Million
  • TABLE 76 Mexico Metabolism Assays Market by Diagnostics Type, 2023 - 2030, USD Million
  • TABLE 77 Mexico Metabolism Assays Market by Technology, 2019 - 2022, USD Million
  • TABLE 78 Mexico Metabolism Assays Market by Technology, 2023 - 2030, USD Million
  • TABLE 79 Mexico Metabolism Assays Market by End User, 2019 - 2022, USD Million
  • TABLE 80 Mexico Metabolism Assays Market by End User, 2023 - 2030, USD Million
  • TABLE 81 Rest of North America Metabolism Assays Market, 2019 - 2022, USD Million
  • TABLE 82 Rest of North America Metabolism Assays Market, 2023 - 2030, USD Million
  • TABLE 83 Rest of North America Metabolism Assays Market by Product, 2019 - 2022, USD Million
  • TABLE 84 Rest of North America Metabolism Assays Market by Product, 2023 - 2030, USD Million
  • TABLE 85 Rest of North America Metabolism Assays Market by Application, 2019 - 2022, USD Million
  • TABLE 86 Rest of North America Metabolism Assays Market by Application, 2023 - 2030, USD Million
  • TABLE 87 Rest of North America Metabolism Assays Market by Diagnostics Type, 2019 - 2022, USD Million
  • TABLE 88 Rest of North America Metabolism Assays Market by Diagnostics Type, 2023 - 2030, USD Million
  • TABLE 89 Rest of North America Metabolism Assays Market by Technology, 2019 - 2022, USD Million
  • TABLE 90 Rest of North America Metabolism Assays Market by Technology, 2023 - 2030, USD Million
  • TABLE 91 Rest of North America Metabolism Assays Market by End User, 2019 - 2022, USD Million
  • TABLE 92 Rest of North America Metabolism Assays Market by End User, 2023 - 2030, USD Million
  • TABLE 93 key Information - Merck KGaA
  • TABLE 94 Key Information - Thermo Fisher Scientific, Inc.
  • TABLE 95 key information - Abcam Plc
  • TABLE 96 key Information - Agilent Technologies, Inc.
  • TABLE 97 key Information - Promega Corporation
  • TABLE 98 Key Information - Kaneka Eurogentec S.A
  • TABLE 99 Key Information - RayBiotech Life, Inc.
  • TABLE 100 Key Information - Sartorius AG
  • TABLE 101 Key Information - Elabscience Biotechnology Inc.
  • TABLE 102 Key Information - BMG LABTECH GmbH
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!